Colartix® , hydrolysed collagen type II matrix delivering multiple joint health benefits
Extracted from natural sources, Colartix® is a unique hydrolysed cartilage matrix that contains hydrolysed collagen Type II in the form of bioactive peptides and other matrix components. Its unique composition contains the same matrix ingredients, found in human cartilage as well. Its effects on users:
Colartix® provides multiple joint health benefits, including reduction of joint inflammation.
Colartix effects on joint health, as demonstrated in scientific studies
Colartix® has been shown to be an effective joint health ingredient in a recent set of in vivo studies. Its efficacy was demonstrated in the context of injury-related osteoarthritis, as well as a combined mouse model of post-traumatic and obesity-induced osteoarthritis.
In a model for post-traumatic osteoarthritis, joint injury induces the loss of cartilage (matrix and cells) and a strong local inflammation of the knee joint. Supplementation with Colartix at a low dose clearly demonstrated the following:
|
Protects and lubricates
Cartilage area and number of SafraninO-positive staining cells in knee joint histologies of mice with and without post-traumatic osteoarthritis after a 3 week supplementation with control or Colartix; OA-osteoarthritis. |
|
Reduces Inflammation
TNF mRNA expression in the synovium of mice with and without post-traumatic osteoarthritis after a 3 week supplementation period with control or Colartix; OA-osteoarthritis. |
In a model for obesity-associated osteoarthritis combined with injury, the loss of cartilage (matrix and cells) and local inflammation of the knee joint were induced in an even shorter time. Colartix supplementation at a low dose resulted in a preventative effect helping to:
|
Protects & lubricates in obesity-associated OA
Cartilage area and number of SafraninO-positive staining cells in knee joint histologies of HFD-fed mice with and without post-traumatic osteoarthritis after a 3 week supplementation period with control or Colartix; OA-osteoarthritis. |
Brown staining represents inflammation. In the obese OA – control image, the staining is apparent, while in the obese OA – Colartix® image, there is no staining. |
Reduces inflammation in obesity-associated OA
TNF immunohistochemistry in knee joints of HFD-fed mice with and without post-traumatic osteoarthritis after a 3 week supplementation period with control or Colartix; OA-osteoarthritis; M-meniscus, F-femur, T-tibia. |
Highly bioavailable
Studies have shown Colartix® has a high absorption rate, indicated by high levels of hydroxyproline after one hour of ingestion.
Serum hydroxyproline in mice 1h after ingestion of a Colartix bolus, after a supplementation period of 3 weeks and 12 weeks respectively.
Using Colartix to uniquely position your joint health supplement in the market
If you are a nutraceutical manufacturer seeking to serve consumers who are in pursuit of an active, healthy lifestyle, Colartix® offers you the perfect solution.
Further Information about Colartix® :
Leaflet Colartix® |